GenSight Biologics SA 2023 Annual Report
Company: GenSight Biologics SA
Sector: Professional & technical services
Country: France
Year: 2023
Type: Annual Report
Pages: 356
The report describes GenSight's withdrawal of the European LUMEVOQ® application, continued Phase I/II development of GS030, successful 2023 GMP-batch manufacturing, and major workforce reduction to 16 employees. It also reports that the company was not subject to mandatory non-financial and greenhouse-gas reporting and disclosed only limited environmental and CSR practices.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.